A total of 400 male renal transplant recipients (RTR) were investigated. Data on medical, sexual history, clinical examination and laboratory variables were collected. The severity of erectile dysfunction (ED) was assessed using the International Index of Erectile Function questionnaire. Univariate and multivariate logistic regression analyses were used to determine prognostic variables, which have independent impact on erectile function. ED was detected in 35.8% of the whole group. Current erectile function as compared to pretransplant status was improved, deteriorated or remained static in 44, 12.5 and 43.5% of the evaluated transplant recipients, respectively. After logistic regression analysis, age, hemoglobin level and presence of DM and/or peripheral neuropathy had significant and independent negative impact on erectile function. We concluded that renal transplantation has varying effects on erectile function. ED is highly prevalent among RTR and its pathogenesis is multifactorial.
Introduction
Chronic renal failure (CRF) has been frequently associated with erectile dysfunction (ED), the incidence is variable between 20 and 60%. 1, 2 As a result of the multisystem disease processes present in many uremic men, it is apparent that the pathogenesis of ED is most probably multifactorial. Factors to be considered include peripheral vascular disease, neurogenic abnormalities, hormonal disturbances and medications used for treatment of conditions associated with CRF. These physiological abnormalities may be supplemented by significant psychological stresses and abnormalities resulting from chronic illness and generalized changes in body function. 3 Erectile function usually improves after successful renal transplantation. Salvatierra et al 4 found that 84% of patients with stable renal transplantation function for 3 or more years regained the same level of sexual activity that they had experienced before the onset of uremia. Flechner et al 5 analyzed 23 males with renal allograft survival longer than 10 y and found a renewed and heightened interest in sexual activity in all the evaluated patients. The improvement in erectile function may be due to normalization of metabolic and hormonal functions 6 and improvement of psychological problems of hemodialyzed patients after transplantation. 7 However, several male patients may continue to experience ED in spite of successful renal transplantation. Recent studies showed that 48-56% of renal transplant recipients (RTR) continue to have ED. 8, 9 The ED in RTR is often multifactorial, since pharmacological, endocrine, neurogenic, vascular and psychogenic causes seem to be implicated. 10 For some patients, this procedure has no effect whatsoever on erectile function. 11 The reported literatures about the factors associated with ED after renal transplantation were either old 12, 13 or have been conducted on a limited number 12 and in most of these studies a univariate analysis was only utilized. 9, 12, 13 We have evaluated male RTR at our center to determine the impact of renal transplantation on erectile function and to define the causes and prevalence of ED post-transplant.
Patients and methods
This study included 400 RTRs, who received kidney from living, related donors. The majority of our patients (96.5%) received single transplant and the remaining (3.5%) received a second transplant. In all patients with single graft, the right internal iliac artery was used for end to end arterial anastomosis except for 20 patients in whom end to side anastomosis to common iliac artery (11) and to external iliac artery (9) was done. All patients with second transplant had their first graft arterial anastomosis end-to-end with the right internal iliac artery while the second graft was anastomosed endto-side to the left external iliac artery. At the time of evaluation all of the evaluated patients had functioning renal allograft.
All patients gave their consent to participate in the study. Assessment of the complaints of ED was achieved using the International Index of Erectile Function (IIEF) questionnaire.
14 The degree of erection was assessed on the basis of the score of the six questions from the erectile function domain of the IIEF and classified as mild ED (score 17-25), moderate (score 11-16) and severe dysfunction (score o10). Patients with erection score between 26 and 30 did not suffer from ED. In unmarried RTR, the erectile function was assessed by asking the patient about any notable durable changes of their noncoital erection. IIEF domain scores were calculated for all sexually active patients and were compared to the data of control population. The control population consisted of 109 male volunteers without any history of ED (mean age 56 y, range: 29-89 y). 14 All the 400 patients were interviewed; during interview a complete medical and sexual history was taken to detect any possible risk factors for ED, such as cigarette smoking, hypertension, the use of antihypertensive drugs, diabetes mellitus, peripheral neuropathy and duration of pretransplant dialysis. Particular attention was given to the patient's ability to obtain an erection before renal failure, while on dialysis, and after renal transplantation. The hospital transplant files were reviewed to identify the type of arterial anastomosis done to revascularize the graft, the type of immunosuppressive regimen (whether cyclosporine A based or not) and comorbid medical conditions. In all patients serum creatinine (Cr), hemoglobin (HB), total cholesterol, cyclosporine A (CsA) level, free testosterone, gonadotrophins levels (FSH and LH) and prolactin were determined.
Normal laboratory values were the following:
HBZ11 g%. Total cholesterol of 140-310 mg%. CsA assay was carried out aiming for a window between 100 and 150 ng/ml (whole blood trough level, monoclonal specific, TDx, Abbott Laboratories, USA). The laboratory reference ranges for free testosterone, prolactin, FSH and LH were (2.6-64.8 pg/ml), (1.6-18.7 ng/ml), (1-8 mIU/ml) and (2-12 mIU/ ml), respectively.
The serum titer of FSH, LH and prolactin was established by means of MEIA ((Microparticle Enzyme Immunoassay), Axsym, Abbott Laboratories, USA). The serum titer of free testosterone was determined using radioimmunoassay (DSL (Diagnostic System Laboratories), USA). The rest of the tests were performed using standard laboratory techniques.
Statistical method
The data were processed using SPSS 10.0 for Windows. Different factors were studied in relation to ED. Statistical analysis of the means of continuous variables was performed through use of Student's t-test, analysis of the significance of categorical variables was performed using w 2 -test, with differences resulting in P-value o0.05 were considered statistically significant. Only the significant factors were further studied in a logistic regression analysis (stepwise regression with backward elimination using likelihood ratio).
Results
The complaints of ED was reported by 35.8% of the 400 RTR (age range 18-63 y, mean 37710) and according to IIEF scoring system ED was demonstrated in 43.5% of the 302 sexually active (married) patients (age range 23-63 y, mean 4178 y). Among the 400 RTR, 87.5% either maintained the same level of pretransplant erectile function 43.5% (43.5%) or reported improvement of their erection after transplantation (44%) while 12.5% with normal pretransplant erection reported deterioration of their erectile capabilities. A significant decrease in erectile function (Po0.001), overall satisfaction (Po0.001) and intercourse satisfaction (Po0.001) was observed in male RTR compared to published controls (Table 1) .
Clinical and laboratory characteristics of the RTR group are summarized in Tables 2 and 3 . The mean age and the graft duration were significantly higher in RTR with ED compared to potent ones (Po0.001). Moreover, the severity of ED increased with aging; the percentage of moderate and severe cases of ED increased from 32% in patients below 40 y to 68% in those over 40 y. Diabetes mellitus, graft insufficiency (Cr 42 mg%) and anemia (HBo11 gm%) were more likely to be observed in those with ED compared to potent transplant (Po0.001 and 0.05, respectively). Another variable, which displayed a statistically significant difference between the two groups, was the presence of associated peripheral neuropathy (Po0.05). Among the 400 RTR, 215 (53.7%) received CsA-based immunosuppressive regimen, of whom 53 (24.6%) developed ED post-transplant. Patients with CsA-based immunosuppressive regimens were more likely to have ED (Po0.05). On the other hand, there were no statistically significant differences between both groups as regards the incidence of hypertension (whether sustained (before transplantation) or newly developed), history of smoking, duration of pretransplant dialysis and serum cholesterol. Also there was no impact of the type or the number of antihypertensives on erectile function (Table 4) . In all, 96% of the sample studied displayed normal levels of free testosterone, and no statistically significant difference in serum levels were found in patients with and without ED.
Also no statistical differences were found in serum levels of prolactin, FSH and LH between the two patient groups.
The previously mentioned seven factors, which had a significant impact on the erectile function with univariate analysis, were further evaluated by the logistic regression model to identify variables which had an independent and significant impact on erectile function. With such analysis four factors only: age, HB level, DM and peripheral neuropathy sustained their significance (Table 5) .
Discussion
Initial studies reported the prevalence of ED among RTR to be in the range of 54-66%. 12, 15 Recent studies using IIEF questionnaire, continued to show similar results. 9, 16 Using the same index in our study, a prevalence of 43.5% was found in 302 
sexually active RTR, this shows that in spite of successful renal transplantation, prevalence of ED remains high. The effect of renal transplantation on erectile function was studied since 1970 s, some authors reported improvement of erectile function after renal transplantation, 15 while others reported erectile function deterioration after transplantation. 4, 13 Others reported that in the majority of cases this procedure has no effect whatsoever on the erectile function. 11 In our study, 87.5% of RTR experienced either no alteration in erectile function after renal transplantation (43.5%) or improvement of erectile function after transplantation (44%), while 12.5% reported deterioration of their erectile capabilities after transplantation.
Age has been a matter for consideration in the origin of ED in general population. 17, 18 While evaluating 61 RTR, Nghiem et al 13 found that age was the only factor deleterious to male erectile function. The present study also showed highly significant association between age and ED in RTR. While the average age of patients without complaints of ED was approximately 34 y, the age of patients with ED averaged 43 y, another fact observed, was the increase in the severity of ED with aging. When the age was evaluated in association with other variables in the logistic regression analysis, it remained as one of the strongest factors associated with ED in this group of patients.
In a single variable analysis, our results showed significant differences between RTR with and without ED regarding graft duration. When logistic regression analysis was performed, graft duration did not sustain its significance. It is possible that the age factor acted as a variable of confusion in relation to graft duration. In other words, the greater the age, the longer the duration of the graft. Several other authors also reported no association between graft duration and erectile function. 9, 19 The deleterious vascular effect of chronic renal failure and hemodialysis has been documented both on cavernous tissue and penile distal arteries. 20 In our study, duration of dialysis was not a determinant factor when associated with the presence of ED in the population analyzed; this is supported by other studies. 2 It is worthy to mention that most of our RTR were subjected to dialysis for short duration (mean ¼ 18 months).
In the Massachusetts Male Aging Study, the ageadjusted probability of complete ED was three times greater in diabetic patients on treatment than in those without diabetes. 18 It is reasonable to suppose that diabetic RTR would exhibit an even greater prevalence of ED, as vascular pathology is an important cause of ED in RTR. 20 In the current ED and renal transplantation MS El-Bahnasawy et al study, with logistic regression analysis, DM had a significant negative impact on erectile function (P ¼ 0.001). The probability of ED was three times higher in patients with DM than nondiabetics. Peripheral neuropathy is frequently associated with ED. Peripheral neuropathy that occurs in RTR may be due to associated DM or residual effect of uremia. 3 In the various studies discussing ED in RTR, no single study reported the association between ED and peripheral neuropathy. In our study, 14 patients had peripheral neuropathy of whom 78% had ED. When the regression analysis was performed to assess the relationship between multiple variables and the presence of ED, peripheral neuropathy persisted in the final model, showing a strong relationship with ED.
Since 1980 s, several studies have been performed to assess the relationship between arterial hypertension and ED. 18 In the present study, the incidence of hypertension was similar between groups with and without ED (74 and 69%, respectively, P ¼ 0.3), this finding was also reported by others. 9, 13 Use of antihypertensive drugs is considered to be a risk factor for ED. One study evaluated the association between the existence of ED in RTR and the use of beta-blockers and there was no relationship between the use of such drugs and erectile function. 9 In the present study, the use and the type of antihypertensive drugs did not show any significant correlation with ED in the evaluated group. This could be explained by two points, first is that all our RTR receive nearly the same antihypertensive protocol. The second point is that the antihypertensive protocol consists of calcium blocking agents alone or in combination with angiotensin-converting enzyme (ACE) inhibitors and both drugs have minimal negative impact on erectile function. 21 The association between smoking and ED has been well documented in the literature. On the other hand, some studies reported no association between ED and smoking among RTR. 9 In the current study, 21.5% of the patients were smokers, incidence of smoking was comparable between impotent and potent ones (26 vs 19%, P ¼ 0.13).
It is well known that the kidney plays an integral role in controlling body functions, with renal impairment there may be generalized changes in body function and a higher incidence of ED was reported.
1,2 With univariate analysis our results showed that the prevalence of ED was higher in patients with deteriorated graft function. However, with logistic regression analysis, graft function did not persist in the final model. Several other studies support our findings.
9,13 Also, we found no relation between testosterone and prolactin level and erectile function, this could be explained by the fact that all our RTR had a functioning graft, and none of them returned to dialysis and this may ensure normalization of any uremic endocrinal abnormalities.
Anemia could participate in the etiology of ED in RTR because it worsens the general condition and aggravates asthenia in those patients. Also hypoxia associated with anemia may lead to decreased activity of nitric oxide (NO) synthase enzyme 22 and increase in collagen synthesis 23 resulting in impaired sinusoidal relaxation and ED. Our results showed a significant correlation between anemia (HBo11 g%) and ED, anemic patients had double the chance to have ED than nonanemic patients.
Hypercholesterolemia is one of the significant risk factors in the development of vasculogenic ED. The mechanism of hypercholesterolemia induced dysfunction of the corporal endothelium may be due to impaired ability of the endothelium to synthesize NO 24 or decreased synthesis or availability of L-arginine. 25 Some authors reported the negative impact of hypercholesterolemia on penile hemodynamics. 19 In the current study, no statistically significant relationship between cholesterol level In contrast with the findings of some authors who reported no correlation between CsA and erectile function 9, 19 we found statistically higher incidence of ED among RTR receiving CsA-based immunosuppressive regimens. However, after regression analysis this significance was not sustained. Several issues may link CsA and ED. Firstly, CsA is a proven inhibitor of NO-mediated smooth muscle relaxation essential for erection. 26 Therapeutic CsA levels could induce vascular endothelial cell dysfunction; 27 moreover, CsA was found to increase collagen in endothelial cells 28 and also induces upregulated expression of transforming growth factor b 1 that may induce fibrosis of the corpora cavernosa. 29 The overall impression of sexuality for male RTR was further defined by comparing the scores for all five IIEF domains in the group studied with those of published controls. 12 Lower erectile function, intercourse satisfaction and overall satisfaction scorings were the main sexual problems among RTR despite their younger age (37 vs 56 y). As expected from the classic correction of endocrine disorders and improvement of the psychological status after transplantation; the sexual drive and orgasmic function were comparable to those of the general population.
Conclusions
Renal transplantation can have varying effects on erectile function. In spite of successful renal transplantation, prevalence of ED remains high (35.8%). The pathogenesis of ED in renal transplant patients is multifactorial. Age, anemia and presence of diabetes mellitus and/or peripheral neuropathy were shown to be the main variables associated with ED in RTR.
